A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor Academic Article uri icon

Overview

MeSH Major

  • Carcinoma
  • Chromosomal Proteins, Non-Histone
  • DNA-Binding Proteins
  • Gene Deletion
  • Homozygote
  • Sarcoma
  • Tissue Banks
  • Transcription Factors

abstract

  • NCT02257541 .

publication date

  • January 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1007/s10637-018-0648-z

PubMed ID

  • 30101387

Additional Document Info